查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571545

北美外用皮膚治療市場規模、佔有率和趨勢分析報告：按治療領域、分銷管道、地區和細分市場預測，2024-2030年

North America Topical Skin Treatment Market Size, Share & Trends Analysis Report By Therapeutic Area (Skin Cancer, Eczema, Psoriasis), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 121 Pages | 商品交期: 2-10個工作天內

價格

北美局部皮膚治療市場成長與趨勢：

根據Grand View Research, Inc的最新報告，預計2030年北美局部皮膚治療市場規模將達到124.5億美元，2024年至2030年複合年成長率為9.60%。

在幾個關鍵因素的推動下，北美局部皮膚治療市場正在穩步成長。痤瘡、乾癬和皮膚炎等皮膚病的增加增加了對有效治療的需求。消費者對護膚的意識越來越強，對非處方 (OTC) 解決方案的明顯偏好，進一步增加了需求。此外，隨著人口老化，人們對解決皺紋和老年斑等皮膚老化問題的產品越來越感興趣。

生物技術的進步，特別是奈米技術和藥物輸送系統等領域的進步，正在為更有效和更有針對性的治療鋪平道路。在基因組學和人工智慧突破的推動下，個人化皮膚護膚的趨勢也是一個充滿希望的成長途徑。

北美針對非黑色素瘤皮膚癌 (NMSC) 的局部治療市場預計將取得重大進展，特別是在局部貼片等創新藥物傳遞系統方面。這些進展旨在解決傳統局部療法的局限性，例如藥物滲透性差、局部副作用以及患者用藥依從性的挑戰。

消費者對護膚的認知不斷提高以及先進痤瘡治療方法的可用性是預計推動需求的關鍵因素之一。亞馬遜和沃爾瑪等電子商務平台的興起使這些治療方法更容易獲得，並促進了零售商店和線上藥局的成長。此外，這些平台提供的便利性和多樣性正在鼓勵更多消費者尋找和購買痤瘡治療藥物。

痤瘡治療方案的持續創新是關鍵的成長動力。 Sun Pharma 和 Galderma 等公司分別推出了 Winlevi 和 TWYNEO Cream 等新產品，為痤瘡治療提供新穎有效的解決方案。這些產品副作用更少，效果更好，滿足消費者不斷變化的需求，並且正在推動成長。

策略併購和產品發佈在產業擴張中發揮重要作用。例如，2022 年 1 月，Journey Medical Corporation 收購了 FDA核准的局部米諾四環素產品，擴大了產品系列和地理覆蓋範圍。此外，2021年8月，Sun Pharma 和 Cassiopea 合作在美國和加拿大分銷 Winlevi，標誌著兩家公司擴大商業性影響力的策略舉措。

北美局部皮膚治療市場報告亮點

  • 按治療領域來看，濕疹領域預計將在 2023 年佔據市場主導地位，並在預測期內顯著成長。這種成長是由於濕疹盛行率的上升、意識的提高以及兒童和老年人口的增加。
  • 從分銷通路來看，2023年零售藥局領域佔據市場主導地位。這一優勢得益於廣泛的獲取和消費者的信任、無需處方箋即可獲得產品的便利性以及藥劑師的個人指導。
  • 美國憑藉其強大的醫療基礎設施、高昂的醫療成本和成熟的製藥工業，在北美外用皮膚產品市場佔據主導地位。此外，先進治療方案的可用性，加上製藥公司的大力促銷努力，確保了消費者的高認知度和可及性。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章：北美局部皮膚治療市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
    • 市場機會分析
  • 北美局部皮膚治療市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 價格分析

第4章 北美皮膚外用治療市場：治療領域預估及趨勢分析

  • 北美局部皮膚治療市場：治療領域儀表板
  • 北美局部皮膚治療市場：治療領域變化分析
  • 北美局部皮膚治療市場：按治療領域分類的收益
  • 皮膚癌
  • 濕疹
  • 乾癬
  • 其他治療領域

第5章北美外用皮膚護理市場：通路估算與趨勢分析

  • 北美局部皮膚治療市場：分銷通路儀表板
  • 北美外用皮膚治療市場：通路波動分析
  • 北美局部皮膚治療市場：按通路分類的收益
  • 醫院藥房
  • 零售藥房
  • 其他

第6章北美局部皮膚治療市場：按治療區域和分銷管道分類的區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • Key company market share analysis, 2023
    • Johnson &Johnson Services, Inc.
    • GSK Plc
    • Pfizer, Inc.
    • Novartis AG
    • LEO Pharma A/S
    • AbbVie, Inc.
    • Bausch Health Companies, Inc.
    • Galderma
    • Sun Pharmaceutical Industries Ltd.
Product Code: GVR-4-68040-450-2

North America Topical Skin Treatment Market Growth & Trends:

The North America topical skin treatment market size is anticipated to reach USD 12.45 billion by 2030, growing at a CAGR of 9.60% from 2024 to 2030, according to a new report by Grand View Research, Inc. The topical skin treatment market in North America is seeing steady growth, fueled by several key factors. Rising rates of skin conditions like acne, eczema, psoriasis, and dermatitis have created a growing need for effective treatments. Consumers are becoming more aware of skincare and showing a clear preference for over-the-counter (OTC) solutions, further boosting demand. Additionally, as the population ages, there is increasing interest in products that address skin aging concerns, such as wrinkles and age spots.

Advancements in biotechnology, especially in areas like nanotechnology and drug delivery systems, are paving the way for more effective and targeted treatments. The trend toward personalized skincare, driven by breakthroughs in genomics and artificial intelligence, is also a promising avenue for growth.

The market for topical treatments targeting Nonmelanoma Skin Cancer (NMSC) in North America is expected to witness significant advancements, particularly in innovative drug delivery systems like topical patches. These advancements aim to address the limitations of conventional topical therapies, such as poor drug penetration, local adverse effects, and patient adherence challenges.

Increasing consumer awareness about skincare and the availability of advanced acne treatments is one of the major factors expected to drive demand. The rise of e-commerce platforms, such as Amazon and Walmart, has made these treatments more accessible, contributing to the growth of retail and online pharmacies. Moreover, the convenience and variety offered by these platforms have encouraged more consumers to seek out and purchase acne treatments.

Continuous innovations in acne treatment options are crucial growth drivers. Companies like Sun Pharma and Galderma have introduced new products, such as Winlevi and TWYNEO Cream, respectively, which offer novel & effective solutions for acne treatment. These products provide better outcomes with fewer adverse effects, meeting the evolving needs of consumers and driving growth.

Strategic mergers & acquisitions, along with product launches, play a significant role in industry expansion. For instance, in January 2022, Journey Medical Corporation acquired FDA-approved topical minocycline products, expanding its product portfolio and geographical reach. In addition, in August 2021, Sun Pharma and Cassiopea partnered for the distribution of Winlevi in the U.S. and Canada, highlighting the strategic moves companies are making to enhance their commercial presence.

North America Topical Skin Treatment Market Report Highlights:

  • Based on therapeutic area, the Eczema segment dominated the market in 2023 and is anticipated to grow significantly over the forecast period. This growth is attributed due to the rising prevalence of eczema, increasing awareness, and growing pediatric and geriatric populations.
  • Based on distribution channel, the retail pharmacies segment dominated the market in 2023. This dominance is attributed due to their widespread accessibility and consumer trust, convenience of obtaining products without a prescription, and personalized guidance from pharmacists.
  • U.S. dominated the North America market for topical skin treatment owing to its robust healthcare infrastructure, high healthcare expenditure, and a well-established pharmaceutical industry. Furthermore, the availability of advanced treatment options, coupled with strong promotional efforts from pharmaceutical companies, ensures high consumer awareness and access.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Therapeutic Areas
    • 1.2.2. Distribution Channel
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Therapeutic Areas outlook
    • 2.2.2. Distribution Channel outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. North America Topical Skin Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. High prevalence of skin diseases
      • 3.2.1.2. Increasing adoption of topical treatments
      • 3.2.1.3. Growing demand for faster and more effective results
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Skin irritation and allergies caused by topical drugs
      • 3.2.2.2. Preference for alternative modes of drug delivery
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Emerging biologic topical treatments for psoriasis
      • 3.2.3.2. Innovative topical therapies for nonmelanoma skin cancer
      • 3.2.3.3. Growth potential in advanced acne treatment solutions
  • 3.3. North America Topical Skin Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. North America Topical Skin Treatment Market: Therapeutic Areas Estimates & Trend Analysis

  • 4.1. North America Topical Skin Treatment Market: Therapeutic Areas Dashboard
  • 4.2. North America Topical Skin Treatment Market: Therapeutic Areas Movement Analysis
  • 4.3. North America Topical Skin Treatment Market: By Therapeutic Areas, Revenue (USD million)
  • 4.4. Skin Cancer
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Fluorouracil (5-FU)
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Imiquimod
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Ingenol Mebutate
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Diclofenac Sodium Gel
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Tirbanibulin Ointment
      • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.7. Others
      • 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Eczema
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Corticosteroids
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Calcineurin Inhibitors
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Crisaborole (Eucrisa)
      • 4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.5. Topical Antimicrobials
      • 4.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.6. Emollients and Moisturizers
      • 4.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.7. Others
      • 4.5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Psoriasis
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Corticosteroids
      • 4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Vitamin D Analogues
      • 4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4. Coal Tar
      • 4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.5. Tazarotene
      • 4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.6. Topical Calcineurin Inhibitors
      • 4.6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.7. Combination Therapies
      • 4.6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.8. Others
      • 4.6.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Other therapeutic areas
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. North America topical skin treatment market: Distribution Channel Estimates & Trend Analysis

  • 5.1. North America topical skin treatment market: Distribution Channel Dashboard
  • 5.2. North America topical skin treatment market: Distribution Channel Movement Analysis
  • 5.3. North America topical skin treatment market Estimates and Forecasts, by Distribution Channel, Revenue (USD Million)
  • 5.4. Hospital Pharmacies
    • 5.4.1. Hospital pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Retail Pharmacies
    • 5.5.1. Retail pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Online pharmacies market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. North America topical skin treatment market: Regional Estimates & Trend Analysis By Therapeutic Areas, and Distribution Channel

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company market share analysis, 2023
    • 7.3.2. Johnson & Johnson Services, Inc.
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. GSK Plc
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Pfizer, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Novartis AG
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. LEO Pharma A/S
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. AbbVie, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Bausch Health Companies, Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Galderma
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Sun Pharmaceutical Industries Ltd.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America topical skin treatment market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America topical skin treatment market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 4 North America topical skin treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 5 U.S. North America topical skin treatment market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 6 U.S. topical skin treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 7 Canada topical skin treatment market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 8 Canada topical skin treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 Mexico topical skin treatment market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 10 Mexico topical skin treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 North America Topical Skin Treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic areas and distribution channel snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Pharmaceutical market value, 2023 (USD billion)
  • Fig. 12 Market trends & outlook
  • Fig. 13 Melanoma cases in 2021
  • Fig. 14 Porter's five force analysis
  • Fig. 15 PESTEL analysis
  • Fig. 16 North America topical skin treatment market: Therapeutic areas outlook and key takeaways
  • Fig. 17 North America topical skin treatment market: Therapeutic areas movement analysis
  • Fig. 18 Skin cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Skin cancer cases in 2022
  • Fig. 20 Fluorouracil (5-FU) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Imiquimod market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Ingenol mebutate market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Diclofenac sodium gel market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Tirbanibulin ointment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Eczema market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Prevalence of Atopic Dermatitis (AD) in 2023
  • Fig. 28 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Calcineurin inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Crisaborole (Eucrisa) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Topical antimicrobials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Emollients and moisturizers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Psoriasis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Psoriasis cases (Million)
  • Fig. 36 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Vitamin D analogs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Coal tar market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Tazarotene market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Topical calcineurin inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Combination therapies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 North America topical skin treatment market: Distribution channel outlook and key takeaways
  • Fig. 45 North America topical skin treatment market: Distribution channel movement analysis
  • Fig. 46 Skin cancer, hospital pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Skin cancer, retail pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Skin cancer, other, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Eczema, hospital pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Eczema, retail pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Eczema, other, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Psoriasis, hospital pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Psoriasis, retail pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Psoriasis, other, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Other, hospital pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Other, retail pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 North America topical skin treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 U.S. North America Topical Skin Treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Canada topical skin treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Mexico topical skin treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Market participant categorization
  • Fig. 66 Company market share analysis, 2023
  • Fig. 67 Strategic framework